Spitzer, RL, Kroenke, K, Linzer, M, Hahn, SR, Williams, JB, deGruy, FV 3rd, et al.
Health-related quality of life in primary care patients with
mental disorders. Results from the PRIME-MD 1000 Study.
1995; 274: 1511–7.
Üstun, TB, Ayuso-Mateos, JL, Chatterji, S, Mathers, C, Murray, CJL. Global burden of depressive disorders in the year
2000. Br J Psychiatry
2004; 184: 386–92.
Fernández, A, Bellón, Saameño JA, Pinto-Meza, A, Luciano, JV, Autonell, J, Palao, D, et al.
Burden of chronic physical conditions and mental disorders in
primary care. Br J Psychiatry
2010; 196: 302–9.
Lerner, D, Adler, DA, Chang, H, Lapitsky, L, Hood, MY, Perissinotto, C, et al.
Unemployment, job retention, and productivity loss among
employees with depression. Psychiatr
2004; 55: 1371–8.
Major depressive disorder treatment guidelines in America and
Europe. J Clin Psychiatry
2010; 71 (suppl E1):
American Psychiatric Association. Practice
Guideline for the Treatment of Major Depression Disorder.
National Institute for Health and Clinical Excellence.
Depression: The Treatment and Management of Depression In Adults.
Clinical Guideline 90.
Kessler, RC, Berglund, P, Demler, O, Jin, R, Koretz, D, Merikangas, KR, et al.
The epidemiology of major depressive disorder: results from
the National Comorbidity SurveyReplication (NCS-R).
2003; 289: 3095–105.
Simon, GE, Perlis, RH.
Personalized medicine for depression: can we match patients
Am J Psychiatry
2010; 167: 1445–55.
Papakostas, GI, Fava, M.
Predictors, moderators, and mediators (correlates) of
treatment outcome in major depressive disorder.
Dialogues Clin Neurosci
2008; 10: 439–51.
Frank, E, Cassano, GB, Rucci, P, Thompson, WK, Kraemer, HC, Fagiolini, A, et al.
Predictors and moderators of time to remission of major
depression with interpersonal psychotherapy and SSRI
pharmacotherapy. Psychol Med
2011; 41: 151–62.
De Rubeis, RJ, Hollon, SD, Amsterdam, JD, Shelton, RC, Young, PR, Salomon, RM, et al.
Cognitive therapy vs medications in the treatment of moderate
to severe depression. Arch Gen
2005; 62: 409–16.
Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, et al.
Randomized trial of behavioral activation, cognitive therapy,
and antidepressant medication in the acute treatment of adults with major
depression. J Consult Clin Psychol
2006; 74: 658–70.
Kocsis, JH, Leon, AC, Markowitz, JC, Manber, R, Arnow, B, Klein, DN, et al.
Patient preference as a moderator of outcome for chronic
forms of major depressive disorder treated with nefazodone, cognitive
behavioral analysis system of psychotherapy, or their
combination. J Clin Psychiatry
2009; 70: 354–61.
Fournier, JC, DeRubeis, RJ, Shelton, RC, Hollon, SD, Amsterdam, JD, Gallop, R. Prediction of response to medication and cognitive
therapy in the treatment of moderate to severe
depression. J Consult Clin Psychol
2009; 77: 775–87.
Menchetti, M, Bortolotti, B, Rucci, P, Scocco, P, Bombi, A, Berardi, D, et al.
Depression in primary care: interpersonal counseling vs
selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter
randomized controlled trial. Rationale and design.
2010; 10: 97.
American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders (4th
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al.
The Mini-International Neuropsychiatric Interview (M.I.N.I.):
the development and validation of a structured diagnostic psychiatric
interview for DSM-IV and ICD-10. J Clin
1998; 59 (suppl 20):
Development of a rating scale for primary depressive
illness. Br J Soc Clin Psychol
1967; 6: 278–96.
Klerman, GL, Weissman, MM, Rounsaville, BJ, Chevron, E. Interpersonal Psychotherapy of Depression.
Klerman, GL, Budman, S, Berwick, D, Weissman, MM, Damico-White, J, Demby, A, et al.
Efficacy of a brief psychosocial intervention for symptoms of
stress and distress among patients in primary care.
1987; 25: 1078–88.
Mossey, JM, Knott, KA, Higgins, M, Talerico, K. Effectiveness of a psychosocial intervention,
interpersonal counseling, for subdysthymic depression in medically ill
elderly. J Gerontol A Biol Sci Med Sci
1996; 51: M172–8.
Neugebauer, R, Kline, J, Bleiberg, K, Baxi, L, Markowitz, JC, Rosing, M, et al.
Preliminary open trial of interpersonal counseling for
subsyndromal depression following miscarriage.
2007; 24: 219–22.
Mundt, JC, Marks, IM, Shear, MK, Greist, JH. The Work and Social Adjustment Scale: a simple
measure of impairment in functioning. Br J
2002; 180: 461–4.
Thase, ME, Entsuah, AR, Rudolph, RL. Remission rates during treatment with venlafaxine or
selective serotonin reuptake inhibitors. Br J
2001; 178: 234–41.
McPartlin, GM, Reynolds, A, Anderson, C. A comparison of once daily venlafaxine XR and
paroxetine in depressed outpatients treated in general
practice. Primary Care Psychiatry
1998; 4: 127–32.
Mynors-Wallis, LM, Gath, DH, Day, A, Baker, F. Randomised controlled trial of problem solving
treatment, antidepressant medication, and combined treatment for major
depression in primary care. BMJ
Kraemer, HC, Wilson, GT, Fairburn, CG, Agras, WS. Mediators and moderators of treatment effects in
randomized clinical trials. Arch Gen
2002; 59: 877–83.
Pincus, T, Miles, C, Froud, R, Underwood, M, Carnes, D, Taylor, S. Methodological criteria for the assessment of
moderators in systematic reviews of randomised controlled trials: a
consensus study. BMC Med Res Methodol
2011; 11: 14.
Sun, X, Briel, M, Busse, J, You, J, Akl, E, Mejza, F, et al.
Credibility of claims of subgroup effects in randomised
controlled trials: systematic review.
Kraemer, HC, Kupfer, DJ.
Size of treatment effects and their importance to clinical
research and practice. Biol Psychiatry
2006; 59: 990–6.
Mynors-Wallis, LM, Gath, DH, Lloyd-Thomas, AR, Tomlinson, D. Randomised controlled trial comparing problem
solving treatment with amitriptyline and placebo for major depression in
primary care. BMJ
1995; 310: 441–5.
Brown, C, Schulberg, HC, Madonia, MJ, Shear, MK, Houck, PR. Treatment outcomes for primary care patients with
major depression and lifetime anxiety disorders.
Am J Psychiatry
1996; 153: 1293–300.
Chilvers, C, Dewey, M, Fielding, K, Gretton, V, Miller, P, Palmer, B, et al.
Antidepressant drugs and generic counselling for treatment of
major depression in primary care: randomised trial with patient
preference arms. BMJ
2001; 322: 772–5.
Bortolotti, B, Menchetti, M, Bellini, F, Montaguti, MB, Berardi, D. Psychological interventions for major depression in
primary care: a meta-analytic review of randomized controlled
trials. Gen Hosp Psychiatry
Brown, C, Schulberg, HC, Prigerson, HG. Factors associated with symptomatic improvement and
recovery from major depression in primary care patients.
Gen Hosp Psychiatry
2000; 22: 242–50.
You, S, Conner, KR.
Stressful life events and depressive symptoms: influences of
gender, event severity, and depression history. J
Nerv Ment Dis
2009; 197: 829–33.
Salminen, JK, Karlsson, H, Hietala, J, Kajander, J, Aalto, S, Markkula, J, et al.
Short-term psychodynamic psychotherapy and fluoxetine in
major depressive disorder: a randomized comparative
study. Psychother Psychosom
2008; 77: 351–7.
Hegerl, U, Hautzinger, M, Mergl, R, Kohnen, R, Schütze, M, Scheunemann, W, et al.
Effects of pharmacotherapy and psychotherapy in depressed
primary-care patients: a randomized, controlled trial including a
patients' choice arm. Int J
Brookes, S, Whitely, E, Egger, M, Davey, Smith G, Mulheran, P, Peters, T. Subgroup analyses in randomized trials: risks of
subgroup-specific analyses; power and sample size for the interaction
test. J Clin Epidemiol
2004; 57: 229–36.
Van, HL, Schoevers, RA, Dekker, J. Predicting the outcome of antidepressants and
psychotherapy for depression: a qualitative, systematic
review. Harv Rev Psychiatry
2008; 16: 225–34.